What the label states, the lot delivers — net peptide mass, not gross powder weight, purity reported as measured rather than rounded up, and a Certificate of Analysis for every lot.
Net peptide mass, not powder weight; purity as measured, not rounded up; a COA per lot.
Net peptide + purity not rounded up. COA per lot.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Recombinant erythropoietin protein · heavily regulated
Overview
Erythropoietin (EPO) is an endogenous glycoprotein hormone produced mainly by the kidneys (roughly 90% in adults) and the liver, which regulates the proliferation and differentiation of erythroid precursors in bone marrow. Recombinant human erythropoietin (rHuEPO, e.g., Epoetin alfa/Epoetin beta) is manufactured in CHO cell expression systems with an amino acid sequence identical to endogenous EPO, and is FDA-approved for clinical use in renal anemia and chemotherapy-induced anemia (marketed as EPOGEN, PROCRIT, EPREX). It also serves as an important tool reagent in basic research on hypoxia adaptation, exercise physiology, neuroprotection, and erythropoiesis regulation. Note that EPO is a glycoprotein hormone biologic rather than a conventional synthetic peptide — its molecular weight and structural complexity are far greater than typical research peptides. Vialdyne releases EPO as a lyophilized glycoprotein hormone against a ≥ 99.0% HPLC main-peak specification, with a batch-specific Certificate of Analysis covering RP-HPLC purity, mass-spec identity, water content, residual solvents, and endotoxin. Sequence / identity confirmation is documented on the released lot.
Applications & buyer fit
GH-axis peptides ship to two main buyer types: compounding pharmacies dispensing under physician supervision, and research labs studying somatotropic-axis pharmacology. Pharmacies typically want sterile-filled vials with the full release packet (sterility, endotoxin, CCI); labs typically want loose-format lyophilized powder with sequence verification. Blends (the CJC-1295 / Ipamorelin combination is the canonical example) are usually co-lyophilized rather than solution-mixed for potency stability.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Sterile-filled vials are available with the full release packet (sterility, endotoxin, CCI); loose lyophilized powder ships with sequence verification.
Primary buyer fit: academic and contract research laboratories.
Specifications
Regulatory note
Research-use-only reference material; not for human or veterinary use.
Selected literature
Frequently asked questions
The epoetin and darbepoetin forms and the PEG-conjugated variant share the same protein backbone but differ in glycosylation or conjugation, and they are not interchangeable, so the ordering document must name the exact form and the certificate must confirm it. Qualification of a glycoprotein biologic goes beyond a purity number: a buyer should expect isoform or glycan-pattern characterization consistent with the named product, identity confirmation, and biological-activity data appropriate to a recombinant protein rather than a small-molecule assay. Confirming the batch matches the specified form in writing is the control that prevents substituting one pharmacokinetic profile for another.
As a recombinant protein biologic, EPO demands continuous cold-chain integrity from shipment through storage, unlike a robust lyophilized peptide that tolerates brief ambient excursions. A qualification file should specify the storage temperature range, prohibit freezing where the formulation is a liquid, and require monitored temperature logging with defined excursion-handling and rejection criteria. Because protein activity can be lost silently without any visible change, acceptance should tie to documented chain-of-custody and temperature records rather than appearance alone. These controls belong in the incoming-inspection procedure so that a batch failing temperature history is quarantined before use.
